Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Galectin Therapeutics Inc (GALT)  
$3.03 0.22 (6.77%) as of 4:30 Fri 5/10


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 57,080,000
Market Cap: 172.95(M)
Last Volume: 97,895 Avg Vol: 97,624
52 Week Range: $1.32 - $4.2
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    : 5.4
Insider 6 Months    : 6.1
Insider 3/6 Months : 11.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,500 5,000 6,598 33,898
Total Buy Value $14,360 $15,253 $18,107 $61,191
Total People Bought 3 4 4 5
Total Buy Transactions 3 4 5 12
Total Shares Sold 25,000 25,000 25,000 45,000
Total Sell Value $76,500 $76,500 $76,500 $118,240
Total People Sold 1 1 1 2
Total Sell Transactions 2 2 2 4
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 517
  Page 11 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Lewis Joel Director   –       •      –    2017-12-14 4 A $2.39 $55,001 D/D 23,013 50,880     -
   Rubin Marc Director   –       •      –    2017-12-08 4 B $1.85 $12,972 D/D 7,000 55,581 2.39     -
   Freeman Kevin D Director   –       •      –    2017-12-07 4 B $1.64 $657 D/D 400 28,043 2.31     -
   Freeman Kevin D Director   –       •      –    2017-12-07 4 B $1.63 $13,005 I/I 8,000 8,000 2.1     -
   10x Capital Management, Llc 10% Owner   –       –       •   2017-06-30 4 A $2.42 $230,396 D/D 95,205 3,135,150     -
   Czirr James C Director   –       •      –    2017-06-30 4 A $2.42 $230,396 I/I 95,205 3,135,150     -
   Zucconi Theodore Daniel Director   –       •      –    2017-05-23 4 B $2.27 $2,270 D/D 1,000 1,083 2.31     -
   Uihlein Richard E 10% Owner   –       –       •   2017-04-23 3 IO $0.00 $0 I/I 0 20,000     -
   Uihlein Richard E 10% Owner   –       –       •   2017-04-23 3 IO $0.00 $0 D/D 0 2,509,909     -
   10x Capital Management, Llc 10% Owner   –       –       •   2017-03-31 4 A $1.98 $229,979 D/D 116,151 3,039,945     -
   Czirr James C Director   –       •      –    2017-03-31 4 A $1.98 $229,979 I/I 116,151 3,039,945     -
   Czirr James C Director   –       •      –    2017-03-31 4 A $6.00 $6,000 D/D 1,000 888,630     -
   10x Capital Management, Llc 10% Owner   –       –       •   2017-01-27 4 OE $3.00 $167,502 D/D 55,834 2,629,519     -
   Czirr James C Director   –       •      –    2016-12-31 4/A A $1.01 $213,995 I/I 211,876 2,923,794     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-12-31 4/A A $1.01 $213,995 D/D 211,876 2,923,794     -
   Czirr James C Director   –       •      –    2016-12-31 4 A $1.01 $213,995 D/D 211,876 3,452,303     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-12-31 4 A $1.01 $213,995 D/D 211,876 3,452,303     -
   Zucconi Theodore Daniel Director   –       •      –    2016-12-15 3 IO $0.00 $0 D/D 0 83     -
   Czirr James C Director   –       •      –    2016-11-10 4 D $0.78 $20,872 I/I (26,759) 3,169,356     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-11-10 4 D $0.78 $20,872 D/D (26,759) 3,169,356     -
   Czirr James C Director   –       •      –    2016-10-13 4 D $1.13 $259,203 I/I (229,383) 3,196,115     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-10-13 4 D $0.86 $197,269 D/D (229,383) 3,196,115     -
   10x Capital Management, Llc 10% Owner   –       –       •   2016-09-30 4/A D $1.13 $856,418 D/D (757,892) 2,711,918     -
   Czirr James C Director   –       •      –    2016-09-30 4/A D $1.13 $856,418 I/I (757,892) 2,711,918     -
   Czirr James C Director   –       •      –    2016-09-30 4 A $1.13 $1,130 D/D 1,000 887,630     -

  517 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed